Evaluation of mean corpuscular volume among anemic people with HIV in North America following ART initiation
Lang R, Coburn S, Gill M, Justice A, Grossman J, Gebo K, Horberg M, Mayor A, Silverberg M, McGinnis K, Hogan B, Moore R, Althoff K. Evaluation of mean corpuscular volume among anemic people with HIV in North America following ART initiation. AIDS Research And Therapy 2024, 21: 52. PMID: 39113038, PMCID: PMC11304803, DOI: 10.1186/s12981-024-00641-4.Peer-Reviewed Original ResearchConceptsAntiretroviral therapy initiationAntiretroviral therapyNormocytic anemiaMicrocytic anemiaMean corpuscular volumeRisk factorsMacrocytic anemiaAssociated with increased morbidityCausative factors of anemiaProportion of PWHFactors of anemiaAssociated with increasing ageClassification of anemiaIdentified risk factorsAnemic peopleCD4 countHIV factorsNA-ACCORDLow hemoglobinAnemiaPWHEstimate crudeRobust varianceHemoglobin measurementsHIVCOVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration
Soyer E, McGinnis K, Justice A, Hsieh E, Rodriguez-Barradas M, Williams E, Park L. COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration. AIDS And Behavior 2024, 28: 3605-3614. PMID: 39046612, DOI: 10.1007/s10461-024-04449-1.Peer-Reviewed Original ResearchHIV statusSubstance use disordersBreakthrough infectionRisk of breakthroughAssociated with increased riskCOVID-19 breakthrough infectionsSARS-CoV-2Association of substance useSARS-CoV-2 infectionHIV treatment adherenceCD4 countHIV progressionSubstance useUnited States Veterans Health AdministrationHazard ratioIncreased riskPWHCD4PWoHHIVUse disorderVaccinated personsCohort of peopleTreatment adherenceLongitudinal cohort